Watch for Amputation Concerns With Diabetes Med Invokana

July 2017

Concerns about amputation with canagliflozin (Invokana, etc) will have patients asking about the safety of SGLT2 inhibitors.

This is the latest in a growing list of flozin concerns...ketoacidosis, UTIs, yeast infections, etc.

Amputations, mainly of the toe or mid-foot, are seen in about 6 in 1,000 patients taking canagliflozin per year...compared to about 3 in 1,000 patients per year on other diabetes meds.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Opioids Try Non-Opioid Options First for Chronic Noncancer Pain
Osteoporosis Sort Through Meds for Osteoporosis in Postmenopausal Women
Corticosteroids Know the Risks and Benefits of Short-Course Steroids
Heart Failure Don't Jump to Newer Drugs for Systolic Heart Failure
Antipsychotics Explain How Rexulti Compares to Other Atypical Antipsychotics
Transdermal Patches Help Avoid Common Errors With Transdermal Patches
UTIs Clarify How to Prevent Recurrent UTIs
Statins Re-Evaluate Statin Use in Older Patients WithOUT CV Disease
Anticoagulants Double-Check Dosing of Direct Oral Anticoagulants (DOACs) in Certain Patients
Musculoskeletal Explain Options for Treating Nighttime Leg Cramps
Diabetes Watch for Amputation Concerns With Diabetes Med Invokana
Med Adherence Take Steps to Reduce the Number of Return-to-Stock Rxs

Watch for Amputation Concerns With Diabetes Med Invokana

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents